Enterprise Value
-19.37M
Cash
56.37M
Avg Qtr Burn
-10.85M
Short % of Float
0.62%
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
SIG-005 Details MPS-1 (Mucopolysaccharidosis Type 1) | Phase 1/2 Initiation | |
SIG-001 Details Hemophilia | Failed Discontinued |